Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
about
Heart failure and Alzheimer's diseaseRisk assessment for incident heart failure in individuals with atrial fibrillation.Lone atrial fibrillation: does it exist?The prevalence and prognosis of resistant hypertension in patients with heart failure.Right heart dysfunction in heart failure with preserved ejection fractionAtrial fibrillation ablation and left appendage closure in heart failure patientsAtrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction.Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillationIMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial.Acute heart failure with preserved ejection fraction: unique patient characteristics and targets for therapy.Atrial Fibrillation Associated with Heart Failure, Stroke and Mortality.Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study.Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.Atrial fibrillation in heart failure.Heart failure highlights in 2011.Comorbidity of atrial fibrillation and heart failure.Urine measurement indicates the plasma brain natriuretic peptide concentration during optimization of heart failure treatment.Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.Albumin levels predict survival in patients with heart failure and preserved ejection fraction.Atrial fibrillation and prognosis in patients 80+ years old with chronic heart failure.The prognostic significance of atrial fibrillation in heart failure with a preserved and reduced left ventricular function: insights from a meta-analysis.Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel?Clinical predictors of outcome in patients with inflammatory dilated cardiomyopathy.Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).The prognostic significance of atrial fibrillation in heart failure with preserved ejection function: insights from KaRen, a prospective and multicenter study.Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction.Neurohormonal and clinical sex differences in heart failure.Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project.Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation.Echo and heart failure: when do people need an echo, and when do they need natriuretic peptides?A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
P2860
Q26852526-CC61B336-D10A-47B8-828C-9F0FFEC68B2FQ30559212-D3B9501F-38E1-4B4E-9AD6-633AFD517775Q33560948-F46653C2-4D5A-4E06-9B29-6C293BD4A83AQ34663396-F700274A-9685-474B-8F7D-9739AB371BBAQ35588220-BE8319C5-898B-453A-BFC0-5F8AAFB2B559Q35755766-D2DFB728-BC66-4458-B102-463FF7D5A0E0Q36535510-B14EB3AA-07A3-4C32-BD71-A92C8FFE28F4Q36623045-E1AEF6EA-E50A-40F3-A994-7F633A79605FQ37355944-64DD3C05-0E14-41C8-866D-81E1C66C60A9Q37408637-07F4C932-FD74-4494-8B1A-7D0601E64F1DQ37495856-9E172092-2F19-4C17-8AE5-10629B6C8C18Q37543186-4C921903-30CA-474D-AEBB-FA6FA8BC9EAEQ37678145-DBF68D06-EA28-4CD3-B901-8BD7DAFD0FAAQ38032181-FDA78DF0-891C-40AB-9350-E10292827092Q38035177-26DABDEF-6A53-497E-9836-38F82AB68AF5Q38666884-F1CB5729-C037-461F-8BA8-862483B36C46Q40312541-86324A43-F0A2-439C-8B3A-C371E25254E5Q43546438-CDEBACD0-7A8C-4085-81DD-7F362AF397D5Q43889667-3252E759-09AE-4D04-A19A-26B1B618ED74Q43973175-3D9EFE1B-07C4-457F-B891-FB0A63404AA4Q44238442-E90E2E86-71FB-4958-8EA2-2386575CF75EQ44689964-77F528E4-7676-461E-9D03-D0DE52611765Q47335254-E096A93C-0398-4D4C-B8B0-398608A556ADQ47599527-93F2F631-F7F7-4A88-98DD-6DE184366B28Q47906558-ED65D7FB-4771-407A-86D3-F3304BA3D115Q50099011-3EEB41DB-29AE-4D71-97FE-AF825AB5FD7DQ51000455-6FE31DED-6DB7-47F1-9E63-95A02A2A33F2Q51363743-DCF5EECC-3508-417C-8CDE-CD14AFB904A9Q52586010-F7279375-9ADA-49ED-B306-389BA79541D3Q55346961-DA277E47-4E25-4D36-95E1-66197A9F0D9EQ58796635-1C7A1CEA-A0A1-4AD6-B1D6-50835FD6ED86
P2860
Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Clinical and prognostic effect ...... ventricular ejection fraction.
@en
Clinical and prognostic effect ...... ventricular ejection fraction.
@nl
type
label
Clinical and prognostic effect ...... ventricular ejection fraction.
@en
Clinical and prognostic effect ...... ventricular ejection fraction.
@nl
prefLabel
Clinical and prognostic effect ...... ventricular ejection fraction.
@en
Clinical and prognostic effect ...... ventricular ejection fraction.
@nl
P2093
P2860
P50
P356
P1476
Clinical and prognostic effect ...... ventricular ejection fraction.
@en
P2093
Adriaan A Voors
Gerard C M Linssen
Hans L Hillege
Isabelle C van Gelder
P2860
P304
P356
10.1093/EURJHF/HFR066
P577
2011-06-03T00:00:00Z